Buscar en
Archivos de la Sociedad Española de Oftalmología (English Edition)
Toda la web
Inicio Archivos de la Sociedad Española de Oftalmología (English Edition) Choroidal neovascularization secondary to angioid streaks: A familial case repor...
Journal Information
Vol. 89. Issue 5.
Pages 190-193 (May 2014)
Share
Share
Download PDF
More article options
ePub
Visits
1372
Vol. 89. Issue 5.
Pages 190-193 (May 2014)
Short communication
DOI: 10.1016/j.oftale.2014.07.003
Choroidal neovascularization secondary to angioid streaks: A familial case report
Neovascularización coroidea secundaria a estrías angioides: un caso familiar
Visits
...
J. Benitez-Herreros
Corresponding author
jbenitezherreros@hotmail.com

Corresponding author.
, C. Camara-Gonzalez, L. Lopez-Guajardo, C. Beckford-Torngren, J. Pareja-Esteban
Servicio de Oftalmología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (4)
Show moreShow less
Abstract
Case report

We report a familial case of 2 siblings that suffered choroidal neovascularization (CNV) secondary to angioid streaks. They were both treated with a monthly intravitreal injection of ranibizumab (Lucentis®) for 3 months. Visual acuity was stabilized and fluorescein angiography revealed complete resolution of CNV. Neither recurrent CNV lesion nor new hemorrhages were reported during the follow-up period.

Discussion

The use of intravitreal ranibizumab for the treatment of CNV in patients with angioid streaks has shown favorable results. However, further studies with a longer follow-up and larger number of patients are necessary to more precisely determine the results of this therapy.

Keywords:
Angioid streaks
Choroidal neovascularization
Ranibizumab
Lucentis
Pseudoxanthoma elasticum
Resumen
Caso clínico

Se expone el caso de dos hermanos que presentaron neovascularización coroidea asociada a estrías angioides. Ambos pacientes fueron tratados con una inyección mensual de ranibizumab (Lucentis®) intravítrea durante tres meses. La visión se estabilizó y la angiografía fluoresceínica mostró resolución completa de la neovascularización coroidea. Durante el seguimiento, no observamos recurrencia del cuadro.

Discusión

El uso de ranibizumab intravítreo en caso de neovascularización coroidea asociada a estrías angioides ha mostrado resultados favorables. No obstante, serán necesarias series de casos mayores que nos permitan conocer la verdadera eficacia de este tratamiento.

Palabras clave:
Estrías angioides
Neovascularización coroidea
Ranibizumab
Lucentis
Pseudoxantoma elástico

Article

These are the options to access the full texts of the publication Archivos de la Sociedad Española de Oftalmología (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Archivos de la Sociedad Española de Oftalmología (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos